Compensation award — excluded from discretionary-purchase analysis.
Loading…
Menelas N Pangalos is Director at Biogen. OQRO lists 3 transactions filed with the SEC under this name, the latest on Jun 11, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
1
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.